BiotechTube
Home/Satellos Bioscience/Dr. Philip Lambert
DP

Dr. Philip Lambert

Chief Development Officer

Satellos Bioscience

Therapeutic Areas

Muscular DystrophyRegenerative Medicine

Satellos Bioscience Pipeline

DrugIndicationPhase
SAT-3153Duchenne Muscular Dystrophy (DMD)Phase 1

Leadership Team at Satellos Bioscience

FG
Frank Gleeson
President & Chief Executive Officer
DM
Dr. Michael Rudnicki
Chief Scientific Officer & Founder
DR
Dr. Ryan Wiley
Head of Strategy & Partnerships
DJ
Dr. John Mendlein
Chair of the Board of Directors
View full Satellos Bioscience profile